# Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

> **NCT03813095** · PHASE2 · UNKNOWN · sponsor: **Aphios** · enrollment: 32 (estimated)

## Conditions studied

- Addiction
- Opioid Dependence
- Opioid Withdrawal

## Interventions

- **DRUG:** APH-1501
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03813095
- **Lead sponsor:** Aphios
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03813095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03813095, "Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03813095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*